Sanara MedTech (SMTI) Competitors $32.66 +0.09 (+0.28%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SMTI vs. BLFS, PLSE, SSII, MDXG, BBNX, INMD, IRMD, TNDM, EMBC, and AXGNShould you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include BioLife Solutions (BLFS), Pulse Biosciences (PLSE), SS Innovations International (SSII), MiMedx Group (MDXG), Beta Bionics (BBNX), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Embecta (EMBC), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry. Sanara MedTech vs. Its Competitors BioLife Solutions Pulse Biosciences SS Innovations International MiMedx Group Beta Bionics InMode iRadimed Tandem Diabetes Care Embecta AxoGen BioLife Solutions (NASDAQ:BLFS) and Sanara MedTech (NASDAQ:SMTI) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations. Which has higher earnings & valuation, BLFS or SMTI? Sanara MedTech has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Sanara MedTech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$82.25M13.77-$20.18M-$0.12-197.00Sanara MedTech$97.24M2.99-$9.66M-$1.16-28.16 Is BLFS or SMTI more profitable? BioLife Solutions has a net margin of -5.39% compared to Sanara MedTech's net margin of -10.22%. BioLife Solutions' return on equity of 0.16% beat Sanara MedTech's return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-5.39% 0.16% 0.14% Sanara MedTech -10.22%-26.43%-10.69% Do institutionals & insiders have more ownership in BLFS or SMTI? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 8.1% of Sanara MedTech shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 42.6% of Sanara MedTech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, BLFS or SMTI? BioLife Solutions has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.19, indicating that its share price is 19% more volatile than the S&P 500. Do analysts prefer BLFS or SMTI? BioLife Solutions currently has a consensus price target of $31.29, suggesting a potential upside of 32.34%. Sanara MedTech has a consensus price target of $50.00, suggesting a potential upside of 53.09%. Given Sanara MedTech's higher possible upside, analysts clearly believe Sanara MedTech is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer BLFS or SMTI? In the previous week, BioLife Solutions had 3 more articles in the media than Sanara MedTech. MarketBeat recorded 4 mentions for BioLife Solutions and 1 mentions for Sanara MedTech. BioLife Solutions' average media sentiment score of 1.01 beat Sanara MedTech's score of 0.68 indicating that BioLife Solutions is being referred to more favorably in the media. Company Overall Sentiment BioLife Solutions Positive Sanara MedTech Positive SummaryBioLife Solutions beats Sanara MedTech on 12 of the 17 factors compared between the two stocks. Get Sanara MedTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMTI vs. The Competition Export to ExcelMetricSanara MedTechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$290.74M$10.41B$5.70B$10.23BDividend YieldN/A1.90%5.68%4.61%P/E Ratio-28.1620.2376.0426.13Price / Sales2.9930.44516.68165.77Price / CashN/A24.3737.5661.52Price / Book7.343.3512.676.32Net Income-$9.66M$212.47M$3.29B$270.94M7 Day Performance-5.72%-2.57%0.09%-0.10%1 Month Performance-0.82%-3.99%4.14%6.37%1 Year Performance12.54%-10.62%65.69%28.45% Sanara MedTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMTISanara MedTech2.1107 of 5 stars$32.66+0.3%$50.00+53.1%+10.5%$290.74M$97.24M-28.1660BLFSBioLife Solutions2.9528 of 5 stars$25.06-0.9%$31.29+24.8%-2.7%$1.20B$82.25M-208.65440Positive NewsPLSEPulse Biosciences4.2093 of 5 stars$17.61+0.3%$22.00+24.9%+3.1%$1.18B$700K-16.71140Positive NewsInsider TradeGap UpSSIISS Innovations InternationalN/A$5.90-3.8%N/AN/A$1.14B$20.65M0.004MDXGMiMedx Group3.4419 of 5 stars$7.15-0.5%$12.00+67.7%+19.6%$1.06B$348.88M34.04870Positive NewsBBNXBeta Bionics1.3214 of 5 stars$23.15+1.1%$23.33+0.8%N/A$1.01B$65.12M0.00294Analyst ForecastINMDInMode2.8556 of 5 stars$14.94-0.5%$18.04+20.8%-10.2%$946.25M$394.82M6.06480Positive NewsIRMDiRadimed4.8156 of 5 stars$71.02+0.4%$72.00+1.4%+44.3%$907.19M$73.24M44.02110Positive NewsInsider TradeTNDMTandem Diabetes Care4.2539 of 5 stars$13.27+1.6%$22.44+69.1%-72.2%$896.92M$940.20M-4.302,650EMBCEmbecta4.2233 of 5 stars$14.81+1.5%$19.00+28.3%-3.1%$866.24M$1.12B10.362,100Positive NewsAXGNAxoGen3.0914 of 5 stars$17.91+1.8%$26.00+45.2%+21.0%$825.42M$187.34M-179.38450 Related Companies and Tools Related Companies BioLife Solutions Competitors Pulse Biosciences Competitors SS Innovations International Competitors MiMedx Group Competitors Beta Bionics Competitors InMode Competitors iRadimed Competitors Tandem Diabetes Care Competitors Embecta Competitors AxoGen Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMTI) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanara MedTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanara MedTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
